Oridis Biomarkers GmbH

https://www.oridis-biomarkers.com

ORIDIS Biomarkers is a Contract Research Organization specializing in cancer research, designing and performing retrospective and prospective custom-made tissue- and body fluid studies, integrating clinical data and molecular pathology analysis. ORIDIS Biomarkers offer solutions in the fields of biomarker evaluation, patient stratification, antibody profiling and diagnostic assay development utilizing our core enabling technologies including FISH, IHC and our NIH-licensed tissue microarray and propriety image capture technology. *

	Start	2011-07-23 renamed before
	Predecessor	Oridis Biomed Forschungs- und Entwicklungs GmbH
	Industry	biomarker
	Person	Feurstein, Burkhard (Oridis Biomarkers 201205– CEO + Partner at GCP gamma capital partners)
	Person 2	Otte, Marcus (Oridis Biomarkers 201107 COO)

	Region	Graz
	Country	Austria
	Street	5 Stiftingtalstr.
	City	8010 Graz
	Tel	+43-316-325-776
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)